URGN icon

UroGen Pharma
URGN

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$33
33% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Raghuram Selvaraju
75% 1-yr URGN win rate
27 Oct ‘25 1 month ago
D. Boral Capital
D. Boral Capital
Jason Kolbert
71% 1-yr URGN win rate
27 Oct ‘25 1 month ago